Overexpression of TET dioxygenases in seminomas associates with low levels of DNA methylation and hydroxymethylation

Germ cell tumors and particularly seminomas reflect the epigenomic features of their parental primordial germ cells (PGCs), including genomic DNA hypomethylation and expression of pluripotent cell markers. Because the DNA hypomethylation might be a result of TET dioxygenase activity, we examined expression of TET1‐3 enzymes and the level of their product, 5‐hydroxymethylcytosine (5hmC), in a panel of histologically characterized seminomas and non‐seminomatous germ cell tumors. Expression of TET dioxygenase mRNAs was quantified by real‐time PCR. TET1 expression and the level of 5hmC were examined immunohistochemically. Quantitative assessment of 5‐methylcytosine (5mC) and 5hmC levels was done by the liquid chromatography‐mass spectroscopy technique. We found highly increased expression of TET1 dioxygenase in most seminomas and strong TET1 staining in seminoma cells. Isocitrate dehydrogenase 1 and 2 mutations were not detected, suggesting the enzymatic activity of TET1. The levels of 5mC and 5hmC in seminomas were found decreased in comparison to non‐seminomatous germ cell tumors and healthy testicular tissue. We propose that TET1 expression should be studied as a potential marker of seminomas and mixed germ cell tumors and we suggest that elevated expression of TET dioxygenase enzymes is associated with the maintenance of low DNA methylation levels in seminomas. This “anti‐methylator” phenotype of seminomas is in contrast to the CpG island methylator phenotype (CIMP) observed in a fraction of tumors of various types.

[1]  Andrew Menzies,et al.  Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes , 2014, Science.

[2]  Li-Xuan Qin,et al.  Identification and validation of a gene expression signature that predicts outcome in adult men with germ cell tumors. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  S. Nakagawa,et al.  De novo DNA methylation drives 5hmC accumulation in mouse zygotes , 2016, Nature Cell Biology.

[4]  David R. Liu,et al.  Conversion of 5-Methylcytosine to 5- Hydroxymethylcytosine in Mammalian DNA by the MLL Partner TET1 , 2009 .

[5]  D. Kučerová,et al.  Epigenetic regulation of transcription and splicing of syncytins, fusogenic glycoproteins of retroviral origin , 2011, Nucleic acids research.

[6]  E. Rajpert-De Meyts,et al.  Evidence that active demethylation mechanisms maintain the genome of carcinoma in situ cells hypomethylated in the adult testis , 2013, British Journal of Cancer.

[7]  G. Kristiansen,et al.  Analysis of TET Expression/Activity and 5mC Oxidation during Normal and Malignant Germ Cell Development , 2013, PloS one.

[8]  L. Looijenga,et al.  Testicular germ-cell tumours in a broader perspective , 2005, Nature Reviews Cancer.

[9]  J. Issa,et al.  TET2 Mutations Affect Non-CpG Island DNA Methylation at Enhancers and Transcription Factor-Binding Sites in Chronic Myelomonocytic Leukemia. , 2015, Cancer research.

[10]  Tin-Lap Lee,et al.  Hypermethylation of genes in testicular embryonal carcinomas , 2015, British Journal of Cancer.

[11]  A. Pavlícek,et al.  CpG methylation suppresses transcriptional activity of human syncytin-1 in non-placental tissues. , 2006, Experimental cell research.

[12]  A. Feinberg,et al.  Hypomethylation distinguishes genes of some human cancers from their normal counterparts , 1983, Nature.

[13]  Yang Wang,et al.  Tet-Mediated Formation of 5-Carboxylcytosine and Its Excision by TDG in Mammalian DNA , 2011, Science.

[14]  Klaus Rajewsky,et al.  TET proteins and 5‐methylcytosine oxidation in hematological cancers , 2015, Immunological reviews.

[15]  Bin Wang,et al.  Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases. , 2011, Cancer cell.

[16]  N. Skakkebæk,et al.  Epigenetic features of testicular germ cell tumours in relation to epigenetic characteristics of foetal germ cells. , 2013, The International journal of developmental biology.

[17]  A. Bird.  DNA methylation patterns and epigenetic memory. , 2002, Genes & development.

[18]  T. Ulbright.  The Most Common, Clinically Significant Misdiagnoses in Testicular Tumor Pathology, and How to Avoid Them , 2008, Advances in anatomic pathology.

[19]  Christian Schwager,et al.  Embryonic Stem Cell-Like Features of Testicular Carcinoma in Situ Revealed by Genome-Wide Gene Expression Profiling , 2004, Cancer Research.

[20]  Anindya Dutta,et al.  p21 in cancer: intricate networks and multiple activities , 2009, Nature Reviews Cancer.

[21]  L. Sobin,et al.  TNM Classification of Malignant Tumours , 1987, UICC International Union Against Cancer.

[22]  Chuan He,et al.  Tet Proteins Can Convert 5-Methylcytosine to 5-Formylcytosine and 5-Carboxylcytosine , 2011, Science.

[23]  A. Olshen,et al.  Gene expression-based classification of nonseminomatous male germ cell tumors , 2005, Oncogene.

[24]  N. Skakkebaek,et al.  Diagnostic markers for germ cell neoplasms: from placental-like alkaline phosphatase to micro-RNAs. , 2015, Folia histochemica et cytobiologica.

[25]  Yuting Liu,et al.  Role of Tet1 in erasure of genomic imprinting , 2013, Nature.

[26]  A. Kohlmann,et al.  Landscape of TET2 mutations in acute myeloid leukemia , 2012, Leukemia.

[27]  F. Mallet,et al.  Custom human endogenous retroviruses dedicated microarray identifies self-induced HERV-W family elements reactivated in testicular cancer upon methylation control , 2010, Nucleic acids research.

[28]  P. Humphrey,et al.  The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours. , 2016, European urology.

[29]  A. Califano,et al.  Mechanism and Role of SOX2 Repression in Seminoma: Relevance to Human Germline Specification , 2016, Stem cell reports.

[30]  W. Ansorge,et al.  Genome-wide gene expression profiling of testicular carcinoma in situ progression into overt tumours , 2005, British Journal of Cancer.

[31]  J. Hicks,et al.  Global DNA hypomethylation in intratubular germ cell neoplasia and seminoma, but not in nonseminomatous male germ cell tumors , 2008, Modern Pathology.

[32]  J. Richter,et al.  Global DNA methylation in fetal human germ cells and germ cell tumours: association with differentiation and cisplatin resistance , 2010, The Journal of pathology.

[33]  S. Bezerra,et al.  Global 5-Hydroxymethylcytosine Levels Are Profoundly Reduced in Multiple Genitourinary Malignancies , 2016, PloS one.

[34]  H. Schöler,et al.  Oct4 is required for primordial germ cell survival , 2004, EMBO reports.

[35]  W. Chan,et al.  microRNA-199a-3p, DNMT3A, and aberrant DNA methylation in testicular cancer , 2014, Epigenetics.

[36]  Z. Ling,et al.  Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation , 2013, Oncogene.

[37]  Peter A. Jones,et al.  A decade of exploring the cancer epigenome — biological and translational implications , 2011, Nature Reviews Cancer.

[38]  R. McLendon,et al.  IDH1 and IDH2 mutations in gliomas. , 2009, The New England journal of medicine.

[39]  S. Baylin,et al.  DNA methylation patterns of the calcitonin gene in human lung cancers and lymphomas. , 1986, Cancer research.

[40]  J. Uhm.  IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype , 2012 .

[41]  G. Kristiansen,et al.  BMP Inhibition in Seminomas Initiates Acquisition of Pluripotency via NODAL Signaling Resulting in Reprogramming to an Embryonal Carcinoma , 2015, PLoS genetics.

[42]  H. Ng,et al.  Human DNA-(cytosine-5) methyltransferase-PCNA complex as a target for p21WAF1. , 1997, Science.

[43]  N. Skakkebæk,et al.  Carcinoma in situ testis displays permissive chromatin modifications similar to immature foetal germ cells , 2010, British Journal of Cancer.

[44]  M. Ehrlich,et al.  Amount and distribution of 5-methylcytosine in human DNA from different types of tissues of cells. , 1982, Nucleic acids research.

[45]  D. Kučerová,et al.  Overexpression of TET dioxygenases in seminomas , 2017 .

[46]  H. Leffers,et al.  Stem cell pluripotency factor NANOG is expressed in human fetal gonocytes, testicular carcinoma in situ and germ cell tumours , 2005, Histopathology.

[47]  Riitta Lahesmaa,et al.  Tet1 and Tet2 regulate 5-hydroxymethylcytosine production and cell lineage specification in mouse embryonic stem cells. , 2011, Cell stem cell.

[48]  H. Herbst,et al.  Human endogenous retrovirus (HERV)‐K transcripts in germ cell and trophoblastic tumours , 1998, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[49]  D. Haussler,et al.  The Somatic Genomic Landscape of Glioblastoma , 2013, Cell.

[50]  J. Kononen,et al.  POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. , 2003, Cancer research.

[51]  H. Stoop,et al.  Expression and interdependencies of pluripotency factors LIN28, OCT3/4, NANOG and SOX2 in human testicular germ cells and tumours of the testis. , 2011, International journal of andrology.

[52]  J. Herman,et al.  CpG island methylator phenotype in colorectal cancer. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[53]  Rui Liu,et al.  Tet1 controls meiosis by regulating meiotic gene expression , 2012, Nature.

[54]  N. Skakkebaek,et al.  Developmental expression of POU5F1 (OCT-3/4) in normal and dysgenetic human gonads. , 2004, Human reproduction.

[55]  Hai Yan,et al.  A heterozygous IDH1R132H/WT mutation induces genome-wide alterations in DNA methylation , 2012, Genome research.

[56]  L. Liau,et al.  Cancer-associated IDH1 mutations produce 2-hydroxyglutarate , 2009, Nature.

[57]  P. Hájková,et al.  DNA demethylation, Tet proteins and 5-hydroxymethylcytosine in epigenetic reprogramming: an emerging complex story. , 2014, Genomics.

[58]  A. Olshen,et al.  Down-regulation of stem cell genes, including those in a 200-kb gene cluster at 12p13.31, is associated with in vivo differentiation of human male germ cell tumors. , 2006, Cancer research.

[59]  S. Oliviero,et al.  TET1 is a tumour suppressor that inhibits colon cancer growth by derepressing inhibitors of the WNT pathway , 2014, Oncogene.

[60]  R. Exner,et al.  Potential of DNA methylation in rectal cancer as diagnostic and prognostic biomarkers , 2015, British Journal of Cancer.

[61]  B. Iacopetta,et al.  CpG island methylator phenotype is an independent predictor of survival benefit from 5-fluorouracil in stage III colorectal cancer. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[62]  Peter A. Jones,et al.  The Epigenomics of Cancer , 2007, Cell.

[63]  E. Rajpert-De Meyts.  Developmental model for the pathogenesis of testicular carcinoma in situ: genetic and environmental aspects. , 2006, Human reproduction update.

[64]  H. Aburatani,et al.  Three DNA Methylation Epigenotypes in Human Colorectal Cancer , 2009, Clinical Cancer Research.

[65]  K. Roemer,et al.  Human endogenous retrovirus rec interferes with germ cell development in mice and may cause carcinoma in situ, the predecessor lesion of germ cell tumors , 2005, Oncogene.

[66]  Peter A. Jones,et al.  The fundamental role of epigenetic events in cancer , 2002, Nature Reviews Genetics.

[67]  M. Ehrlich,et al.  5-Methylcytosine in eukaryotic DNA. , 1981, Science.

[68]  P. Humphrey,et al.  SALL4 Is a Novel Diagnostic Marker for Testicular Germ Cell Tumors , 2009, The American journal of surgical pathology.